Therefore, CEA and CYFRA21-1 seem to have a better performance when monitoring adenocarcinoma patients, whereas the low number of squamous carcinoma patients did not allow to draw a conclusion in this sense. The gene discussed is CEACAM5; the disease is adenocarcinoma.